Quality of antibiotic use for lower respiratory tract infections at hospitals: (How) can we measure it?

Clinical Infectious Diseases

Volumn 41, Issue 4, 2005, Pages 450-460

  Schouten, J A ^a   Hulscher, M E J L ^a   Wollersheim, H ^a   Braspennning, J ^a   Kullberg, B J ^a   Van Der Meer, J W M ^a   Grol, R P T M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COMMUNITY ACQUIRED PNEUMONIA; CONSENSUS; COST CONTROL; DRUG UTILIZATION; EVIDENCE BASED MEDICINE; FACTORIAL ANALYSIS; FEASIBILITY STUDY; FOLLOW UP; HEALTH STATUS; HOSPITAL CARE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RELIABILITY; REVIEW;

ANTI-BACTERIAL AGENTS; CONSENSUS; DRUG UTILIZATION; EVIDENCE-BASED MEDICINE; HOSPITALS; HUMANS; NETHERLANDS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES; RESPIRATORY TRACT INFECTIONS;

EID: 23244455896     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/431983     Document Type: Review

References (57)

1. Ortqvist A. Treatment of community-acquired lower respiratory tract infections in adults. Eur Respir J Suppl 2002; 36:40s-53s.
2. ERS Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections. European Respiratory Society. Eur Respir J 1998; 11:986-91.
3. British Thoracic Society guidelines for the management of community-acquired pneumonia in adults. Thorax 2001; 56(Suppl 4):IV1-64.
4. Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000; 31:347-82.
5. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163:1730-54.
6. van Kasteren ME, Wijnands WJ, Stobberingh EE, et al. Optimization of the antibiotics policy in the Netherlands, II. SWAB guidelines for the antimicrobial therapy of community-acquired pneumonia [in Dutch]. Dutch Foundation of the Working Party on Antibiotic Policy. Ned Tijdschr Geneeskd 1998; 142:952-6.
7. van Kasteren ME, Wijnands WJ, Stobberingh EE, et al. Optimizing of antibiotics policy in the Netherlands. III. SWAB guidelines for antimicrobial therapy in adults hospitalized with bronchitis [in Dutch]. Dutch Foundation of the Working Party on Antibiotic Policy. Ned Tijdschr Geneeskd. 1998; 142:2512-5.
8. Grol R, Baker R, Moss F. Quality improvement research: understanding the science of change in health care. London: BMJ Publishing Group, 2004.
9. Lawrence M, Olesen F. Indicators of quality in health care. Eur J Gen Pract 1997; 3:103-8.
10. Rhew DC, Goetz MB, Shekelle PG. Evaluating quality indicators for patients with community-acquired pneumonia. Jt Comm J Qual Improv 2001; 27:575-90.
11. Campbell SM, Braspenning J, Hutchinson A, Marshall MN. Research methods used in developing and applying quality indicators in primary care. BMJ 2003; 326:816-9.
12. Campbell SM, Hann M, Hacker J, et al. Quality assessment for three common conditions in primary care: validity and reliability of review criteria developed by expert panels for angina, asthma and type 2 diabetes. Qual Saf Health Care 2002; 11:125-30.
13. Rubin HR, Pronovost P, Diette GB. From a process of care to a measure: the development and testing of a quality indicator, Int J Qual Health Care 2001; 13:489-96.
14. Quality of care improvements for patients with pneumonia. Florida Medical Quality Assurance. Eval Health Prof 1998; 21:514-24.
15. Battleman DS, Callahan M, Thaler HT. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. Arch Intern Med 2002; 162:682-8.
16. Bratzler DW, Murray CK, Bumpus LJ, Moore LL. Community-acquired pneumonia in Oklahoma: characteristics and management of hospitalized Medicare beneficiaries. J Okla State Med Assoc 1996; 89:87-92.
17. Chu LA, Bratzler DW, Lewis RJ, et al. Improving the quality of care for patients with pneumonia in very small hospitals. Arch Intern Med 2003; 163:326-32.
18. Dedier J, Singer DE, Chang Y, et al. Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med 2001; 161:2099-104.
19. Fine JM, Fine MJ, Galusha D, et al. Patient and hospital characteristics associated with recommended processes of care for elderly patients hospitalized with pneumonia: results from the medicare quality indicator system pneumonia module. Arch Intern Med 2002; 162:827-33.
20. Fortune G, Elder S, Jaco D, et al. Opportunities for improving the care of patients with community-acquired pneumonia. Clin Perform Qual Health Care 1996; 4:41-3.
21. Jencks SF, Guerdon T, Burwen DR, et al. Quality of medical care delivered to Medicare beneficiaries: a profile at state and national levels. JAMA 2000; 284:1670-6.
22. Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997; 278: 2080-4.
23. Metersky ML, Galusha DH, Meehan TP. Improving the care of patients with community-acquired pneumonia: a multihospital collaborative QI project. Jt Comm J Qual Improv 1999; 25:182-90.
24. Nathwani D, Williams F, Winter J, et al. Use of indicators to evaluate the quality of community-acquired pneumonia management. Clin Infect Dis 2002; 34:318-23.
25. Rhew DC. Quality indicators for the management of pneumonia in vulnerable elders. Ann Intern Med 2001; 135:736-43.
26. Schade CP, Cochran BF, Stephens MK. Using statewide audit and feedback to improve hospital care in West Virginia. Jt Comm J Qual Saf 2004; 30:143-51.
27. Barlow GD, Lamping DL, Davey PG, Nathwani D. Evaluation of outcomes in community-acquired pneumonia: a guide for patients, physicians, and policy-makers. Lancet Infect Dis 2003; 3:476-88.
28. Halm EA, Horowitz C, Silver A, et al. Limited impact of a multicenter intervention to improve the quality and efficiency of pneumonia care. Chest 2004; 126:100-7.
29. Lawrence SJ, Shadel BN, Leet TL, et al. An intervention to improve antibiotic delivery and sputum procurement in patients hospitalized with community-acquired pneumonia. Chest 2002; 122:913-9.
30. Malone DC, Shaban HM. Adherence to ATS guidelines for hospitalized patients with community-acquired pneumonia. Ann Pharmacother 2001; 35:1180-5.
31. Meehan TP, Weingarten SR, Holmboe ES, et al. A statewide initiative to improve the care of hospitalized pneumonia patients: the Connecticut Pneumonia Pathway Project. Am J Med 2001; 111:203-10.
32. Yealy DM, Auble TE, Stone RA, et al. The emergency department community-acquired pneumonia trial: methodology of a quality improvement intervention. Ann Emerg Med 2004; 43:770-82.
33. Milo LA, Smucker W, Logue E, et al. Shoot, ready, aim: pneumonia care quality and costs in a community hospital. Am J Med Qual 2003; 18:214-9.
34. Cantrill JA, Sibbald B, Buetow S. Indicators of the appropriateness of long-term prescribing in general practice in the United Kingdom: consensus development, face and content validity, feasibility, and reliability. Qual Health Care 1998; 7:130-5.
35. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159-74.
36. Streiner D, Norman G. Health measurement scales. 2nd ed. Oxford: Oxford University Press, 1994.
37. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243-50.
38. Houck PM, Bratzler DW, Nsa W, et al. Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004; 164:637-44.
39. Menendez R, Ferrando D, Valles JM, Vallterra J. Influence of deviation from guidelines on the outcome of community-acquired pneumonia. Chest 2002; 122:612-7.
40. Ramirez JA, Vargas S, Ritter GW, et al. Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia. Arch Intern Med 1999; 159:2449-54.
41. Rhew DC, Tu GS, Ofman J, et al. Early switch and early discharge strategies in patients with community-acquired pneumonia: a meta-analysis. Arch Intern Med 2001; 161:722-27.
42. Leibovici L, Shraga I, Andreassen S. How do you choose antibiotic treatment? BMJ 1999; 318:1614-6.
43. Nathwani D, Rubinstein E, Barlow G, Davey P. Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care? Clin Infect Dis 2001; 32:728-41.
44. Gleason PP, Meehan TP, Fine JM, et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999; 159:2562-72.
45. Rello J, Catalan M, Diaz E, et al. Associations between empirical antimicrobial therapy at the hospital and mortality in patients with severe community-acquired pneumonia. Intensive Care Med 2002; 28:1030-5.
46. Baddour LM, Yu VL, Klugman KP, et al. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med 2004; 170:440-4.
47. Martinez FJ. Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients. Clin Infect Dis 2004; 38(Suppl 4):S328-40.
48. Stahl JE, Barza M, Desjardin J, et al. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia. Arch Intern Med 1999; 159:2576-80.
49. Waterer GW, Somes GW, Wunderink RG. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 2001; 161:1837-42.
50. Campbell SG, Marrie TJ, Anstey R, et al. The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: a prospective observational study. Chest 2003; 123:1142-50.
51. Waterer GW, Jennings SG, Wunderink RG. The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia. Chest 1999; 116:1278-81.
52. Lettinga KD, Verbon A, Weverling GJ, et al. Legionnaires' disease at a Dutch flower show: prognostic factors and impact of therapy. Emerg Infect Dis 2002; 8:1448-54.
53. Saint S, Bent S, Vittinghoff E, Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations: a meta-analysis. JAMA 1995; 273:957-60.
54. Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106:196-204.
55. Pihlajamaki M, Kotilainen P, Kaurila T, et al. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Clin Infect Dis 2001; 33:483-8.
56. SWAB (Dutch Foundation of the Working Party on Antibiotic Policy). NethMap 2004: consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. Amsterdam: SWAB c/o Department of Infectious Diseases, Tropical Medicine, and AIDS, Academic Medical Centre, 2004.
57. Guyatt GH, Sackett DL, Sinclair JC, et al. Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA. 1995;274:1800-4.